Skip to main content

Biopharma Startups

Updated July 2026

Companies in the biopharma sector developing innovative solutions and technologies.

Explore 854 recently funded biopharma companies with verified founder contact information and fundraising data.

Total Companies
854
Total Funding
$973.3M
Avg Funding
$38.9M
Global Reach
10
countries

Top Cities for Biopharma

Odense
Niigata
Westlake Village
Pittsburgh
Freehold
Vancouver

Recently Funded Companies

Export
Odense, Denmark

GlyProVac is pursuing the development of a glycoprotein based vaccine against Enterotoxigenic Escherichia coli (ETEC).

$467K raised
Feb 2024

Founder Contacts

30,000+ verified contacts

Niigata, Japan

UniBio is a biotech company that aims to produce useful proteins in plant cells via synthesis and the transient gene expression method.

$3.2M raised
Feb 2024

Founder Contacts

30,000+ verified contacts

Westlake Village, United States

Arcutis Biotherapeutics is a clinical-stage biopharmaceutical company focused on developing medical dermatology for unmet needs.

$150.0M raised
Feb 2024

Founder Contacts

30,000+ verified contacts

Pittsburgh, United States

Shaping the Future of Spatially Intelligent Biology

Feb 2023

Founder Contacts

30,000+ verified contacts

Freehold, United States

Avalon GloboCare is a biotech company that develops diagnostics, cellular therapies, along with health tech products.

$9.8M raised
Feb 2026

Founder Contacts

30,000+ verified contacts

Vancouver, Canada

Metabolica Health is a biotechnology company in the development stage that identify and develop novel medicines for diabetes and obesity.

$741K raised
Feb 2024

Founder Contacts

30,000+ verified contacts

Henderson, United States

Zura Bio is a clinical-stage, multi-asset biotechnology company.

$144.0M raised
Feb 2026

Founder Contacts

30,000+ verified contacts

Berkeley, United States

Onyx Bio is a biotech company that offers a virtual immune system for faster and safer development of precision medicines

$8.0M raised
Feb 2026

Founder Contacts

30,000+ verified contacts

Exton, United States

Castle Creek Biosciences is focused on developing commercializing novel, personalized gene therapies for rare skin disorders.

$75.0M raised
Feb 2025

Founder Contacts

30,000+ verified contacts

New York, United States

Cambrian is a distributed development company building therapeutics to lengthen health span.

$30.8M raised
Feb 2026

Founder Contacts

30,000+ verified contacts

Budapest, Hungary

Turbine's platform understands the inner mechanisms of cancer enabling the discovery of novel targets & precision medicinal therapies.

$25.0M raised
Feb 2026

Founder Contacts

30,000+ verified contacts

Cambridge, United States

Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.

$150.0M raised
Feb 2026

Founder Contacts

30,000+ verified contacts

Madison, United States

Stem Pharm's synthetic biomaterials support the optimization of cell expansion.

$75K raised
Feb 2025

Founder Contacts

30,000+ verified contacts

Saintes, Belgium

BioSenic is a forward-thinking firm that aims to address critical unmet medical needs.

$540K raised
Feb 2024

Founder Contacts

30,000+ verified contacts

Gaithersburg, United States

NexImmune is a biopharmaceutical company developing novel immuno-therapeutics based on the proprietary artificial immune technology.

$3.7M raised
Feb 2024

Founder Contacts

30,000+ verified contacts

New York, United States

Roivant Sciences is a biopharmaceutical company focused on the development of medicines and healthcare technologies to patients.

$230.0M raised
Feb 2023

Founder Contacts

30,000+ verified contacts

Glasgow, United Kingdom

Causeway Therapeutics is a clinical-stage biopharmaceutical company specializing in musculoskeletal health.

$10.5M raised
Feb 2023

Founder Contacts

30,000+ verified contacts

Abingdon, United Kingdom

Pioneering a new approach to vaccine development and manufacturing using cutting-edge technologies to produce novel synthetic vaccines.

$667K raised
Feb 2022

Founder Contacts

30,000+ verified contacts

Dublin, Ireland

Amryt Pharma creates and delivers innovative treatments to help patients with rare and orphan diseases live better lives.

$125.0M raised
Feb 2022

Founder Contacts

30,000+ verified contacts

New York, United States

Ambient Multimodal AI for Mental Health

Feb 2025

Founder Contacts

30,000+ verified contacts

Edinburgh, United Kingdom

Lario Therapeutics is a biopharmaceutical firm that develops precision therapeutics for epilepsy and neurological disorders.

$2.4M raised
Feb 2026

Founder Contacts

30,000+ verified contacts

Stockholm, Sweden

Technologies for the next generation of antibody therapies.

Feb 2026

Founder Contacts

30,000+ verified contacts

Albuquerque, United States

YEEO Eco-Safe develops insect control products using plant-derived essential oils combined with yeast encapsulation technology.

$1.1M raised
Feb 2025

Founder Contacts

30,000+ verified contacts

Dundee, United Kingdom

PhaSER Biomedical discovery and develops human like predictions of drug efficacy.

$2.3M raised
Feb 2024

Founder Contacts

30,000+ verified contacts

Madrid, Spain

AptaTargets is a biopharmaceutical company focused in developing therapeutic

Feb 2024

Founder Contacts

30,000+ verified contacts

Showing 401 to 425 of 854 companies

About the Biopharma Startup Ecosystem

The biopharma sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Biopharma

Biopharma companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The biopharma sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Biopharma Funding Breakdown

Here is how funding is distributed among the 854 biopharma companies tracked in the VCBacked database.

Average Funding
$38.9M
Total Funding Tracked
$973.3M
Countries Represented
10

Distribution by Funding Stage

Other25 companies

Top Cities for Biopharma

1.New York
3 companies$260.8M
2.Odense
1 companies$467K
3.Niigata
1 companies$3.2M
4.Westlake Village
1 companies$150.0M
5.Pittsburgh
1 companiesUndisclosed

Related Industries

Companies in the biopharma sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Biopharma Startups?

Perfect for: B2B sales teams targeting biopharma companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

854 Biopharma Startups (2026) — Recently Funded Companies, Investors & Rounds — Page 17 | VCBacked